Hims & Hers Health, Inc. Reports Second Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Hims and Hers (HIMS) PT Lowered to $18 at Jefferies
August 7, 2024 10:16 AM EDTJefferies analyst Glen Santangelo lowered the price target on Hims and Hers (NYSE: HIMS) to $18.00 (from $23.00) while maintaining a Hold rating.
The analyst comments "We are updating our model following 2Q results and management's initial commentary on GLP-1s. We are raising our revenue... More
Hims and Hers (HIMS) PT Raised to $23 at Deutsche Bank
August 6, 2024 4:22 PM EDTDeutsche Bank analyst George Hill raised the price target on Hims and Hers (NYSE: HIMS) to $23.00 (from $16.00) while maintaining a Hold rating.
The analyst comments "Positioned to Grow Specialty Platform: HIMS reported a Q2 beat on a broad basis AMC on Monday where the GLP-1 opportunity in the near term was the overwhelming focus of the earnings call. Since the company... More
Hims & Hers Health, Inc. (HIMS) Tops Q2 EPS by 2c, Offers Guidance
August 5, 2024 4:19 PM EDTHims & Hers Health, Inc. (NYSE: HIMS) reported Q2 EPS of $0.06, $0.02 better than the analyst estimate of $0.04. Revenue for the quarter came in at $315.6 million versus the consensus estimate of $301.6 million.
GUIDANCE:
Hims & Hers Health, Inc. sees Q3 2024 revenue of... More
